The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Requirements: BS/BA degree in Marketing, Business, Life Sciences, or related discipline and 8+ years of relevant pharmaceutical marketing, sales, or pharmaceutical advertising agency experience, including product launch and commercialization experience OR.